![Organic chemistry / Organofluorides / Oncology / Triazoles / Aprepitant / Morpholines / Chemotherapy-induced nausea and vomiting / Cisplatin / 5-HT3 antagonist / Medicine / Chemistry / Antiemetics Organic chemistry / Organofluorides / Oncology / Triazoles / Aprepitant / Morpholines / Chemotherapy-induced nausea and vomiting / Cisplatin / 5-HT3 antagonist / Medicine / Chemistry / Antiemetics](https://www.pdfsearch.io/img/87dcc2da67c80ae76f0b6bc240927070.jpg)
| Document Date: 2009-03-31 14:51:10 Open Document File Size: 189,24 KBShare Result on Facebook
Company MERCK & CO. Inc. / Patients Who Remain Emesis Free / Cycle / Treatment Group / / Event FDA Phase / / Facility Whitehouse Station / / IndustryTerm aprepitant / / MarketIndex Functional Living / / MedicalCondition Secondary Endpoint No Vomiting / chemotherapy-induced nausea / maximum nausea visual analogue scale / Hepatic Insufficiency EMEND / ESRD / Nausea / No Significant Nausea / severe renal insufficiency / vomiting / renal insufficiency / severe hepatic insufficiency / postoperative nausea / vomiting endpoint / mild hepatic insufficiency / renal disease / end stage renal disease / breast cancer / moderate hepatic insufficiency / hepatic insufficiency / significant nausea / Renal Insufficiency A / / MedicalTreatment hemodialysis / chemotherapy / surgery / abdominal surgery / / Organization Oral administration / NS NS / Excretion Following administration / US Federal Reserve / Following administration / / Product EMEND / cisplatin / etoposide / dexamethasone / paclitaxel / cyclophosphamide / fluorouracil / ondansetron / EMEND® (aprepitant) / aprepitant / vomiting / / ProvinceOrState New Jersey / / Technology Pharmacokinetics / Tomography / chemotherapy / /
SocialTag |